Abstract
The covalently bound FAD cofactor in monoamine oxidase (MAO) is reduced by the amine substrate and reoxidized by oxygen. Visible spectroscopy provides a convenient tool to study the interaction of ligands and the kinetics of the half-reactions for mechanistic investigations. Equilibrium redox titrations allow measurement of redox potentials, while rapid mixing experiments allow determination of the rate of reduction by different substrates and of covalent adduct formation by irreversible inactivators. Three techniques are described: (1) measuring ligand interactions by alterations in the spectrum, especially at 495 nm; (2) reducing MAO, including the essentials for anaerobic procedures; and (3) studying kinetics of reduction, reoxidation, or inactivation of MAO.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
Edmondson DE, Binda C, Mattevi A (2007) Structural insights into the mechanism of amine oxidation by monoamine oxidases A and B. Arch Biochem Biophys 464:269–276
Hynson RMG, Wouters J, Ramsay RR (2003) Monoamine oxidase A inhibitory potency and flavin perturbation are influenced by different aspects of pirlindole inhibitor structure. Biochem Pharmacol 65:1867–1874
Jones TZE, Fleming P, Eyermann CJ, Gravestock MB, Ramsay RR (2005) Orientation of oxazolidinones in the active site of monoamine oxidase. Biochem Pharmacol 70:407–416
Sablin SO, Ramsay RR (2001) Substrates but not inhibitors alter the redox potentials of monoamine oxidases. Antioxid Redox Signal 3:723–729
Newton-Vinson P, Edmondson DE (1999) High-level expression, structural, kinetic, and redox characterization of recombinant human liver monoamine oxidase B. In: Ghisla S, Kroneck P, Macheroux P, Sund H (eds) Flavins and flavoproteins 1999. Rudolf Weber, Berlin, pp 431–434
Tan AK, Ramsay RR (1993) Substrate-specific enhancement of the oxidative half-reaction of monoamine-oxidase. Biochemistry 32:2137–2143
Miller JR, Edmondson DE (1999) Structure-activity relationships in the oxidation of para- substituted benzylamine analogues by recombinant human liver monoamine oxidase-A. Biochemistry 38:13670–13683
Nandigama RK, Edmondson DE (2000) Structure-activity relations in the oxidation of phenethylamine analogues by recombinant human liver monoamine oxidase-A. Biochemistry 39:15258–15265
Dunn RV, Marshall KR, Munro AW, Scrutton NS (2008) The pH dependence of kinetic isotope effects in monoamine oxidase A indicates stabilization of the neutral amine in the enzyme-substrate complex. FEBS J 275:3850–3858
Weyler W, Salach JI (1985) Purification and properties of mitochondrial monoamine-oxidase type-A from human placenta. J Biol Chem 260:3199–3207
Weyler W, Titlow CC, Salach JI (1990) Catalytically active monoamine-oxidase type-A from human liver expressed in Saccharomyces-cerevisiae contains covalent FAD. Biochem Biophys Res Commun 173:1205–1211
Li M, Hubalek F, Newton-Vinson P, Edmondson DE (2002) High-level expression of human liver monoamine oxidase A in Pichia pastoris: comparison with the enzyme expressed in Saccharomyces cerevisiae. Protein Expr Purif 24:152–162
Wang J, Edmondson DE (2010) High-level expression and purification of rat monoamine oxidase A (MAO A) in Pichia pastoris: comparison with human MAO A. Protein Expr Purif 70:211–217
Ma JC, Yoshimura M, Yamashita E, Nakagawa A, Ito A, Tsukihara T (2004) Structure of rat monoamine oxidase A and its specific recognitions for substrates and inhibitors. J Mol Biol 338:103–114
Salach JI (1979) Mono-amine oxidase from beef-liver mitochondria - simplified isolation procedure, properties, and determination of its cysteinyl flavin content. Arch Biochem Biophys 192:128–137
Newton-Vinson P, Hubalek F, Edmondson DE (2000) High-level expression of human liver monoamine oxidase B in Pichia pastoris. Protein Expr Purif 20:334–345
Kalgutkar AS, Dalvie DK, Castagnoli N, Taylor TJ (2001) Interactions of nitrogen-containing xenobiotics with monoamine oxidase (MAO) isozymes A and B: SAR studies on MAO substrates and inhibitors. Chem Res Toxicol 14:1139–1162
Youdim MBH, Edmondson DE, Tipton KF (2006) The therapeutic potential of monoamine oxidase inhibitors. Nat Rev Neurosci 7:295–309
Finberg JPM, Rabey JM (2016) Inhibitors of MAO-A and MAO-B in psychiatry and neurology. Front Pharmacol 7:340
Hong RY, Li X (2019) Discovery of monoamine oxidase inhibitors by medicinal chemistry approaches. Medchemcomm 10:10–25
Juarez-Jimenez J, Mendes E, Galdeano C, Martins C, Silva DB, Marco-Contelles J, Carreiras MC, Luque FJ, Ramsay RR (2014) Exploring the structural basis of the selective inhibition of monoamine oxidase A by dicarbonitrile aminoheterocycles: role of Asn181 and Ile335 validated by spectroscopic and computational studies. BBA-Proteins Proteomics 1844:389–397
Hynson, RMG, Kelly, SM, Price, NC, Ramsay, RR (2004) Conformational changes in monoamine oxidase A in response to ligand binding or reduction. BBA – General Subjects 1672:60–66
Jones TZE, Balsa D, Unzeta M, Ramsay RR (2007) Variations in activity and inhibition with pH: the protonated amine is the substrate for monoamine oxidase, but uncharged inhibitors bind better. J Neural Transm 114:707–712
Tasca F, Fierro A, Noell G (2019) Spectroelectrochemical study revealing the redox potential of human monoamine oxidase A. Electrochim Acta 317:612–617
Massey V (1991) A simple method for the determination of redox potentials. In: Curti B, Ronchi S, Zanetti G (eds) Flavins and flavoproteins. Walter de Gruyter, Berlin, pp 55–59
Ramsay RR (1991) Kinetic mechanism of monoamine oxidase-A. Biochemistry 30:4624–4629
Hubalek F, Binda C, Li M, Herzig Y, Sterling J, Youdim MBH, Mattevi A, Edmondson DE (2004) Inactivation of purified human recombinant monoamine oxidases A and B by rasagiline and its analogues. J Med Chem 47:1760–1766
Esteban G, Allan J, Samadi A, Mattevi A, Unzeta M, Marco-Contelles J, Binda C, Ramsay RR (2014) Kinetic and structural analysis of the irreversible inhibition of human monoamine oxidases by ASS234, a multi-target compound designed for use in Alzheimer's disease. BBA-Prot Proteomics 1844:1104–1110
Albreht A, Vovk I, Mavri J, Marco-Contelles J, Ramsay RR (2018) Evidence for a cyanine link between propargylamine drugs and monoamine oxidase clarifies the inactivation mechanism. Front Chem 6:169
Copeland RA (2000) Enzymes: a practical introduction to structure, mechanism, and data analysis, 2nd edn. Wiley, New York, pp 318–349
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2023 The Author(s), under exclusive license to Springer Science+Business Media, LLC, part of Springer Nature
About this protocol
Cite this protocol
Ramsay, R.R. (2023). MAO Visible Spectroscopy for Ligand Interactions, Redox Chemistry, and Kinetics of Irreversible Inhibition. In: Binda, C. (eds) Monoamine Oxidase. Methods in Molecular Biology, vol 2558. Humana, New York, NY. https://doi.org/10.1007/978-1-0716-2643-6_6
Download citation
DOI: https://doi.org/10.1007/978-1-0716-2643-6_6
Published:
Publisher Name: Humana, New York, NY
Print ISBN: 978-1-0716-2642-9
Online ISBN: 978-1-0716-2643-6
eBook Packages: Springer Protocols